NanoString Technologies GeoMx DSP Protein Assays for NGS
NanoString Technologies has launched its GeoMx DSP Protein assays for next-generation sequencing readout.
The assays expand the multiplex detection capabilities of GeoMx digital spatial profiling from tens to hundreds of proteins and include more than 50 targets for immuno-oncology applications. The assays also provide complementary protein content for the GeoMx Cancer Transcriptome Atlas panel.
The firm said it has tested performance on both formalin-fixed, paraffin-embedded and fresh frozen tissue samples.
The products are available immediately through NanoString's technology access program.